Wild-type C-Raf gene dosage and dimerization drive prostate cancer metastasis

被引:0
作者
Ta, Lisa [1 ]
Tsai, Brandon L. [2 ]
Deng, Weixian [3 ]
Sha, Jihui [3 ]
Varuzhanyan, Grigor [4 ]
Tran, Wendy [4 ]
Wohlschlegel, James A. [3 ]
Carr-Ascher, Janai R. [5 ,6 ]
Witte, Owen N. [1 ,4 ,7 ,8 ,9 ,10 ]
机构
[1] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[5] Univ Calif Davis, Dept Internal Med, Div Hematol Oncol, Sacramento, CA 95817 USA
[6] Univ Calif Davis, Dept Orthoped Surg, Sacramento, CA 95817 USA
[7] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA
[8] Univ Calif Los Angeles, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA
[9] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
[10] Univ Calif Los Angeles, Parker Inst Canc Immunotherapy, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
SIGNALING PATHWAYS; KINASE-ACTIVITY; BRAF; PHOSPHORYLATION; INHIBITORS; EXPRESSION; CRAF; ACTIVATION; MECHANISMS; SUFFICIENT;
D O I
10.1016/j.isci.2023.108480
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mutated Ras and Raf kinases are well-known to promote cancer metastasis via flux through the Ras/Raf/MEK/ ERK (mitogen-activated protein kinase [MAPK]) pathway. A role for non-mutated Raf in metastasis is also emerging, but the key mechanisms remain unclear. Elevated expression of any of the three wild-type Raf family members (C, A, or B) can drive metastasis. We utilized an in vivo model to show that wild-type C-Raf overexpression can promote metastasis of immortalized prostate cells in a gene dosage-dependent manner. Analysis of the transcriptomic and phosphoproteomic landscape indicated that C-Raf-driven metastasis is accompanied by upregulated MAPK signaling. Use of C-Raf mutants demonstrated that the dimerization domain, but not its kinase activity, is essential for metastasis. Endogenous Raf monomer knockouts revealed that C-Raf's ability to form dimers with endogenous Raf molecules is important for promoting metastasis. These data identify wild-type C-Raf heterodimer signaling as a potential target for treating metastatic disease.
引用
收藏
页数:17
相关论文
共 73 条
[41]   PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes [J].
Mootha, VK ;
Lindgren, CM ;
Eriksson, KF ;
Subramanian, A ;
Sihag, S ;
Lehar, J ;
Puigserver, P ;
Carlsson, E ;
Ridderstråle, M ;
Laurila, E ;
Houstis, N ;
Daly, MJ ;
Patterson, N ;
Mesirov, JP ;
Golub, TR ;
Tamayo, P ;
Spiegelman, B ;
Lander, ES ;
Hirschhorn, JN ;
Altshuler, D ;
Groop, LC .
NATURE GENETICS, 2003, 34 (03) :267-273
[42]   CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation [J].
Noble, Catherine ;
Mercer, Kathryn ;
Hussain, Jahan ;
Carragher, Linda ;
Giblett, Susan ;
Hayward, Robert ;
Patterson, Cam ;
Marais, Richard ;
Pritchard, Catrin A. .
MOLECULAR CELL, 2008, 31 (06) :862-872
[43]   CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition [J].
Noeparast, Amir ;
Giron, Philippe ;
Noor, Alfiah ;
Shahi, Rajendra Bahadur ;
De Brakeleer, Sylvia ;
Eggermont, Carolien ;
Vandenplas, Hugo ;
Boeckx, Bram ;
Lambrechts, Diether ;
De Greve, Jacques ;
Teugels, Erik .
ONCOGENE, 2019, 38 (31) :5933-5941
[44]   An atlas of human kinase regulation [J].
Ochoa, David ;
Jonikas, Mindaugas ;
Lawrence, Robert T. ;
El Debs, Bachir ;
Selkrig, Joel ;
Typas, Athanasios ;
Villen, Judit ;
Santos, Silvia D. M. ;
Beltrao, Pedro .
MOLECULAR SYSTEMS BIOLOGY, 2016, 12 (12)
[45]   BPG: Seamless, automated and interactive visualization of scientific data [J].
P'ng, Christine ;
Green, Jeffrey ;
Chong, Lauren C. ;
Waggott, Daryl ;
Prokopec, Stephenie D. ;
Shamsi, Mehrdad ;
Nguyen, Francis ;
Mak, Denise Y. F. ;
Lam, Felix ;
Albuquerque, Marco A. ;
Wu, Ying ;
Jung, Esther H. ;
Starmans, Maud H. W. ;
Chan-Seng-Yue, Michelle A. ;
Yao, Cindy Q. ;
Liang, Bianca ;
Lalonde, Emilie ;
Haider, Syed ;
Simone, Nicole A. ;
Sendorek, Dorota ;
Chu, Kenneth C. ;
Moon, Nathalie C. ;
Fox, Natalie S. ;
Grzadkowski, Michal R. ;
Harding, Nicholas J. ;
Fung, Clement ;
Murdoch, Amanda R. ;
Houlahan, Kathleen E. ;
Wang, Jianxin ;
Garcia, David R. ;
de Borja, Richard ;
Sun, Ren X. ;
Lin, Xihui ;
Chen, Gregory M. ;
Lu, Aileen ;
Shiah, Yu-Jia ;
Zia, Amin ;
Kearns, Ryan ;
Boutros, Paul C. .
BMC BIOINFORMATICS, 2019, 20 (1)
[46]   Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma [J].
Palanisamy, Nallasivam ;
Ateeq, Bushra ;
Kalyana-Sundaram, Shanker ;
Pflueger, Dorothee ;
Ramnarayanan, Kalpana ;
Shankar, Sunita ;
Han, Bo ;
Cao, Qi ;
Cao, Xuhong ;
Suleman, Khalid ;
Kumar-Sinha, Chandan ;
Dhanasekaran, Saravana M. ;
Chen, Ying-bei ;
Esgueva, Raquel ;
Banerjee, Samprit ;
LaFargue, Christopher J. ;
Siddiqui, Javed ;
Demichelis, Francesca ;
Moeller, Peter ;
Bismar, Tarek A. ;
Kuefer, Rainer ;
Fullen, Douglas R. ;
Johnson, Timothy M. ;
Greenson, Joel K. ;
Giordano, Thomas J. ;
Tan, Patrick ;
Tomlins, Scott A. ;
Varambally, Sooryanarayana ;
Rubin, Mark A. ;
Maher, Christopher A. ;
Chinnaiyan, Arul M. .
NATURE MEDICINE, 2010, 16 (07) :793-U94
[47]   RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF [J].
Poulikakos, Poulikos I. ;
Zhang, Chao ;
Bollag, Gideon ;
Shokat, Kevan M. ;
Rosen, Neal .
NATURE, 2010, 464 (7287) :427-U126
[48]   ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers [J].
Rebocho, A. P. ;
Marais, R. .
ONCOGENE, 2013, 32 (26) :3207-3212
[49]   Regulation and role of Raf-1/B-Raf heterodimerization [J].
Rushworth, LK ;
Hindley, AD ;
O'Neill, E ;
Kolch, W .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (06) :2262-2272
[50]   RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression [J].
Sanclemente, Manuel ;
Nieto, Patricia ;
Garcia-Alonso, Sara ;
Fernandez-Garcia, Fernando ;
Esteban-Burgos, Laura ;
Guerra, Carmen ;
Drosten, Matthias ;
Caleiras, Eduardo ;
Martinez-Torrecuadrada, Jorge ;
Santamaria, David ;
Musteanu, Monica ;
Barbacid, Mariano .
CANCER CELL, 2021, 39 (03) :294-296